AdaptHealth Corp has a consensus price target of $14.68, established from looking at the 33 latest analyst ratings. The last 3 analyst ratings were released from RBC Capital, UBS, and Truist Securities on March 4, 2024, February 28, 2024, and February 28, 2024. With an average price target of $13 between RBC Capital, UBS, and Truist Securities, there's an implied 36.84% upside for AdaptHealth Corp from these 3 analyst ratings.
1calculated from analyst ratings published within the last 3 years
date | ticker | Buy Now | Company | Current price | Upside/Downside | Analyst Firm | Analyst & % Accurate | Price Target Change | Rating Change | Previous / Current Rating | Get Alert |
---|---|---|---|---|---|---|---|---|---|---|---|
03/04/2024 | AHCO | Buy Now | AdaptHealth | $9.50 | 36.84% | RBC Capital | Ben Hendrix | → $13 | Reiterates | Outperform → Outperform | Get Alert |
02/28/2024 | AHCO | Buy Now | AdaptHealth | $9.50 | 36.84% | UBS | Whit Mayo | $9 → $13 | Maintains | Buy | Get Alert |
02/28/2024 | AHCO | Buy Now | AdaptHealth | $9.50 | 36.84% | Truist Securities | David Macdonald | $11 → $13 | Maintains | Buy | Get Alert |
01/29/2024 | AHCO | Buy Now | AdaptHealth | $9.50 | -5.26% | UBS | Whit Mayo | $10 → $9 | Maintains | Buy | Get Alert |
11/08/2023 | AHCO | Buy Now | AdaptHealth | $9.50 | 36.84% | RBC Capital | Ben Hendrix | $18 → $13 | Maintains | Outperform | Get Alert |
11/08/2023 | AHCO | Buy Now | AdaptHealth | $9.50 | -31.58% | B of A Securities | Kevin Fischbeck | → $6.5 | Downgrade | Neutral → Underperform | Get Alert |
11/08/2023 | AHCO | Buy Now | AdaptHealth | $9.50 | 15.79% | Truist Securities | David Macdonald | $14 → $11 | Maintains | Buy | Get Alert |
10/11/2023 | AHCO | Buy Now | AdaptHealth | $9.50 | 47.37% | Truist Securities | David Macdonald | $18 → $14 | Maintains | Buy | Get Alert |
09/22/2023 | AHCO | Buy Now | AdaptHealth | $9.50 | 15.79% | B of A Securities | Joanna Gajuk | $13 → $11 | Maintains | Neutral | Get Alert |
07/13/2023 | AHCO | Buy Now | AdaptHealth | $9.50 | 121.05% | Baird | Eric Coldwell | $20 → $21 | Maintains | Outperform | Get Alert |
06/28/2023 | AHCO | Buy Now | AdaptHealth | $9.50 | 110.53% | Baird | Eric Coldwell | → $20 | Reiterates | Outperform → Outperform | Get Alert |
06/27/2023 | AHCO | Buy Now | AdaptHealth | $9.50 | 110.53% | Baird | Eric Coldwell | $20 → $20 | Reiterates | Outperform → Outperform | Get Alert |
05/11/2023 | AHCO | Buy Now | AdaptHealth | $9.50 | 89.47% | RBC Capital | Ben Hendrix | $24 → $18 | Maintains | Outperform | Get Alert |
05/10/2023 | AHCO | Buy Now | AdaptHealth | $9.50 | 78.95% | Canaccord Genuity | Richard Close | $22 → $17 | Maintains | Buy | Get Alert |
05/10/2023 | AHCO | Buy Now | AdaptHealth | $9.50 | 57.89% | Truist Securities | David Macdonald | $17 → $15 | Maintains | Buy | Get Alert |
05/10/2023 | AHCO | Buy Now | AdaptHealth | $9.50 | 110.53% | Baird | Eric Coldwell | $23 → $20 | Maintains | Outperform | Get Alert |
05/10/2023 | AHCO | Buy Now | AdaptHealth | $9.50 | 18.95% | Deutsche Bank | Pito Chickering | $28 → $11.3 | Downgrade | Buy → Hold | Get Alert |
05/10/2023 | AHCO | Buy Now | AdaptHealth | $9.50 | 15.79% | Stifel | Mathew Blackman | $18 → $11 | Downgrade | Buy → Hold | Get Alert |
05/09/2023 | AHCO | Buy Now | AdaptHealth | $9.50 | 26.32% | B of A Securities | Joanna Gajuk | $21 → $12 | Downgrade | Buy → Neutral | Get Alert |
The latest price target for AdaptHealth (NASDAQ: AHCO) was reported by RBC Capital on March 4, 2024. The analyst firm set a price target for $13.00 expecting AHCO to rise to within 12 months (a possible 36.84% upside). 19 analyst firms have reported ratings in the last year.
The latest analyst rating for AdaptHealth (NASDAQ: AHCO) was provided by RBC Capital, and AdaptHealth reiterated their outperform rating.
The last upgrade for AdaptHealth Corp happened on July 14, 2021 when Baird raised their price target to $36. Baird previously had a neutral for AdaptHealth Corp.
The last downgrade for AdaptHealth Corp happened on November 8, 2023 when B of A Securities changed their price target from N/A to $6.5 for AdaptHealth Corp.
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of AdaptHealth, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for AdaptHealth was filed on March 4, 2024 so you should expect the next rating to be made available sometime around March 4, 2025.
While ratings are subjective and will change, the latest AdaptHealth (AHCO) rating was a reiterated with a price target of $0.00 to $13.00. The current price AdaptHealth (AHCO) is trading at is $9.50, which is within the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.